EXHIBIT 21.1


Subsidiaries of NeoStem, Inc.⁽¹⁾		Jurisdiction of Incorporation/Organization
NeoStem Therapies, Inc.		Delaware
Stem Cell Technologies, Inc.		Florida
NeoStem (China), Inc.		People’s Republic of China
CBH Acquisition LLC		Delaware
China Biopharmaceuticals Holdings, Inc.⁽²⁾		Delaware
Suzhou Erye Pharmaceuticals Company Ltd.⁽²⁾		People’s Republic of China
Progenitor Cell Therapy, LLC		Delaware
PCT Allendale, LLC⁽³⁾		New Jersey
DomaniCell, LLC⁽³⁾		Delaware
Athelos Corporation⁽⁴⁾		Delaware

(1)

Unless otherwise specified, each entity listed in the chart is a wholly-owned direct subsidiary of NeoStem, Inc.

(2)

China Biopharmaceuticals Holdings, Inc. is a wholly-owned subsidiary of CBH Acquisition LLC and holds the 51% interest in Suzhou Erye Pharmaceutical Company Ltd. (“Erye”). Suzhou Erye Economy and Trading Co. Ltd. owns the remaining 49% interest in Erye.

(3)

This entity is a wholly-owned subsidiary of Progenitor Cell Therapy, LLC.

(4)

Progenitor Cell Therapy, LLC holds an 80% interest in this entity.